Psychemedics Corporation welcomed Andrew “Drew” M. Reynolds to the Psychemedics Board of Directors effective April 4th, 2022. Mr. Reynolds will also serve as a member of the Audit, Compensation, and Nominating and Governance Committees. Mr. Reynolds currently serves as a board director and independent consultant to a number of companies.

He has over 25 years-experience and has held positions in strategy, corporate development, sales and marketing, both domestically and internationally. The Company is also announcing that Harry Connick plans to retire from the Psychemedics Board of Directors effective April 4th, 2022.